4//SEC Filing
Fleming Harold Edward 4
Accession 0001209191-21-040291
CIK 0001674416other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:35 PM ET
Size
5.3 KB
Accession
0001209191-21-040291
Insider Transaction Report
Form 4
Fleming Harold Edward
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-10+25,000→ 25,000 totalExercise: $123.71Exp: 2031-06-10→ Common Shares (25,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 10, 2021 with respect to 25,000 Common Shares with 100% of the shares vesting in 36 equal monthly installments.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001857250
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:35 PM ET
- Size
- 5.3 KB